Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

BACKGROUND: Randomized phase III trials are ongoing to investigate the efficacy of nivolumab in malignant pleural mesothelioma (MPM), but real-world data are still scarce. In this real-world study, we investigated the clinical outcomes of nivolumab treatment in pre-treated MPM patients. METHODS: Dat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Autores principales: Cantini, Luca, Belderbos, Robert A., Gooijer, Cornedine J., Dumoulin, Daphne W., Cornelissen, Robin, Baart, Sara, Burgers, Jacobus A., Baas, Paul, Aerts, Joachim G. J. V.
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481613/
https://ncbi.nlm.nih.gov/pubmed/32953495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-686
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares